TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
CGC

Canopy Growth Corp

Healthcare · Drug Manufacturers - Specialty & Generic

0.8765$ -1.6% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Canopy Growth Corp (CGC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,104 million CAD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of CAD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CGC
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
1,668 1,360 1,300 1,286 1,232 1,164 918 905 1,070 1,518 1,119 1,104
494 397 371 358 392 341 295 303 446 720 529 506
240 143 170 192 228 162 114 126 298 510 365 337
272 188 203 195 231 178 131 144 298 510 365 342
55 51 52 51 42 49 53 50 27 45 36 43
88 88 77 85 90 91 96 94 102 145 111 107
346 – – – – – – – – – – –
84 85 43 43 45 44 46 47 48 65 56 56
149 119 104 99 95 90 87 84 81 105 92 88
919 815 800 753 723 573 430 416 334 478 421 415
196 221 235 167 281 97 94 99 81 135 158 167
64 105 119 46 180 22 21 19 14 18 31 43
23 26 29 25 18 29 26 24 18 27 35 29
631 521 493 558 416 438 300 289 226 225 217 211
749 545 500 533 510 591 487 489 736 1,040 698 689
-10,021 -10,238 -10,330 -10,457 -10,585 -10,707 -10,928 -10,970 -10,971 -15,140 -11,138 -11,153
72 83 90 79 87 110 108 188 274 346 385 422

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?